{"id":"combination-therapy-comb","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Combination therapies typically work by targeting multiple pathways or mechanisms simultaneously to improve treatment outcomes beyond what single agents can achieve. The exact composition and mechanism of this particular combination therapy from Lurie Children's Hospital is not specified in available public information, limiting detailed mechanistic characterization.","oneSentence":"A combination therapy approach that uses multiple agents together to enhance therapeutic efficacy, though the specific components and their mechanisms are not publicly detailed.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:06:46.207Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07070466","phase":"PHASE2","title":"Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-10-10","conditions":"Stomach Cancer Stage IV, Esophagus Cancer, Stomach Cancer","enrollment":40},{"nctId":"NCT07211087","phase":"NA","title":"Improving the Treatment of Depression Among Youth With HIV","status":"NOT_YET_RECRUITING","sponsor":"Rhode Island Hospital","startDate":"2026-04-01","conditions":"Depression Disorders, HIV (Human Immunodeficiency Virus)","enrollment":130},{"nctId":"NCT07428486","phase":"PHASE1","title":"A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia","status":"NOT_YET_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2026-08-17","conditions":"Phase I, FLAG Chemotherapy, Lisaftoclax","enrollment":24},{"nctId":"NCT05304065","phase":"PHASE2","title":"Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2022-10-17","conditions":"Suicide, Suicidal, Self-Harm","enrollment":1600},{"nctId":"NCT06298734","phase":"NA","title":"High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial","status":"RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2024-07-01","conditions":"Melanoma (Skin), Skin Cancer, Advanced Melanoma","enrollment":40},{"nctId":"NCT07142421","phase":"PHASE2","title":"A Study of Trifluridine/Tipiracil Combined With Anlotinib as Second-line Treatment for Recurrent and Metastatic Esophageal Squamous Cell Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2025-08-06","conditions":"Esophageal Squamous Cell Carcinoma (ESCC)","enrollment":35},{"nctId":"NCT06855316","phase":"NA","title":"Evaluating Combined Electromagnetic Stimulation for Enhanced Physical and Psychological Recovery in Athletes with DOMS","status":"NOT_YET_RECRUITING","sponsor":"Sierra Varona SL","startDate":"2025-02-24","conditions":"Recovery, Psychological, Transcranial Magnetic Stimulation","enrollment":48},{"nctId":"NCT04598230","phase":"PHASE3","title":"Partners in Caring for Anxious Youth","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ann & Robert H Lurie Children's Hospital of Chicago","startDate":"2021-02-09","conditions":"Anxiety, Separation, Anxiety, Generalized, Anxiety, Social","enrollment":468},{"nctId":"NCT03583086","phase":"PHASE1, PHASE2","title":"Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors","status":"COMPLETED","sponsor":"Vanderbilt-Ingram Cancer Center","startDate":"2018-07-10","conditions":"Thymic Carcinoma, Non-small Cell Lung Cancer, Refractory Thoracic Tumors","enrollment":88},{"nctId":"NCT05290311","phase":"","title":"Long-Term Effects of CBT on Quality of Life in Adults With ADHD","status":"COMPLETED","sponsor":"Amsterdam UMC, location VUmc","startDate":"2022-07-13","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":155},{"nctId":"NCT06460740","phase":"NA","title":"Comb Effect of 4-7-8 Breathing Technique and Stationary Cycle on PP, QOL and Dyspnea in Post CABG Patients.","status":"RECRUITING","sponsor":"Riphah International University","startDate":"2024-01-01","conditions":"Post-cardiac Surgery","enrollment":58},{"nctId":"NCT06244069","phase":"","title":"Clonal Hematopoiesis in Giant Cell Arteritis","status":"NOT_YET_RECRUITING","sponsor":"ASST Fatebenefratelli Sacco","startDate":"2024-03","conditions":"Giant Cell Arteritis, Temporal Arteritis, Clonal Hematopoiesis of Indeterminate Potential","enrollment":326},{"nctId":"NCT04474145","phase":"NA","title":"The Effect of Combined Hydrodilatation, Corticosteroid Injection, and Joint Mobilization for Treament of Frozen Shoulder","status":"COMPLETED","sponsor":"Shin Kong Wu Ho-Su Memorial Hospital","startDate":"2020-08-01","conditions":"Frozen Shoulder, Hydrodilatation, Joint Mobilization","enrollment":70},{"nctId":"NCT00429273","phase":"PHASE4","title":"Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2007-01","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":212},{"nctId":"NCT02939131","phase":"NA","title":"IMPAACT 2002: Cognitive Behavioral Therapy and Medication Management for Treatment of Depression in US Youth With HIV","status":"COMPLETED","sponsor":"International Maternal Pediatric Adolescent AIDS Clinical Trials Group","startDate":"2017-03-06","conditions":"HIV, Depression","enrollment":156},{"nctId":"NCT01468272","phase":"PHASE2","title":"Clinical Pharmacology of CHF 1535 50/6 ug Next DPI in Children 5-11 Years Old","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2011-11","conditions":"Asthma in Children","enrollment":26},{"nctId":"NCT02854878","phase":"NA","title":"Treatment of Head Lice Infestation Using Novel Ultrasonic Comb","status":"COMPLETED","sponsor":"ParaSonic Ltd.","startDate":"2016-11-28","conditions":"Pediculus Capitis","enrollment":23},{"nctId":"NCT03453190","phase":"PHASE4","title":"Apremilast in Combination With Clobetasol Spray for the Treatment of Plaque Psoriasis","status":"UNKNOWN","sponsor":"Washington Dermatology Center","startDate":"2018-02-25","conditions":"Psoriasis","enrollment":20},{"nctId":"NCT02787967","phase":"PHASE2","title":"Clinical Pharmacology of 35/4 NEXThaler® in Children 5-11 Years Old","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2016-08","conditions":"Asthma","enrollment":26},{"nctId":"NCT00789191","phase":"PHASE3","title":"Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2008-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":222},{"nctId":"NCT01049789","phase":"NA","title":"Treatment for Depression Among HIV-Infected Youth","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2010-06","conditions":"HIV, Depression, HIV Infections","enrollment":42},{"nctId":"NCT00770536","phase":"PHASE1","title":"AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR","status":"COMPLETED","sponsor":"Amgen","startDate":"2009-01","conditions":"Cancer, Carcinoma, Fallopian Tube Cancer","enrollment":103},{"nctId":"NCT00762125","phase":"PHASE2","title":"Subgroups of Fibromyalgia Syndrome (FMS): Symptoms, Beliefs, and Tailored Treatment","status":"COMPLETED","sponsor":"University of Washington","startDate":"2005-12","conditions":"Fibromyalgia","enrollment":266},{"nctId":"NCT00498836","phase":"PHASE2","title":"Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma","status":"COMPLETED","sponsor":"Clavis Pharma","startDate":"2007-03","conditions":"Malignant Melanoma","enrollment":18}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":234,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["SSRI plus CBT","COMB","Trifluridine/tipiracil","Anlotinib"],"phase":"phase_3","status":"active","brandName":"Combination therapy (COMB)","genericName":"Combination therapy (COMB)","companyName":"Ann & Robert H Lurie Children's Hospital of Chicago","companyId":"ann-robert-h-lurie-children-s-hospital-of-chicago","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}